Form 4 for LFCR LIFECORE BIOMEDICAL, INC. DE
Accepted 2024-01-22 00:00:00 ET · period of report 2024-01-18 · accession 0001628280-24-001842 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-01-22 | 2024-01-18 | LFCR | Morberg John D | CFO | M - OptEx | — | +17.5K | 131.9K | +15% | — |
| D | 2024-01-22 | 2024-01-18 | LFCR | Morberg John D | CFO | F - Tax | — | -6,283 | 125.6K | -5% | — |
| D | 2024-01-22 | 2024-01-18 | LFCR | Morberg John D | CFO | M - OptEx | $0.00 | -17.5K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-01-18 | M | A | 17,500 | — | 131,900 | D | — | — | (F1) The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. |
| 2 | Common | Common Stock | 2024-01-18 | F | D | 6,283 | — | 125,617 | D | — | — | (F1) The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. |
| 3 | Derivative | Restricted Stock Unit | 2024-01-18 | M | D | 17,500 | $0.00 | 0 | D | — · 2024-01-18 to — | 17,500 Common Stock | (F1) The restricted stock units convert into common stock of Lifecore Biomedical, Inc. on a 1 for 1 basis. (F2) The restricted stock units vested on January 18, 2024. |